» Articles » PMID: 28269534

Addressing Drug-drug and Drug-food Interactions Through Personalized Empowerment Services for Healthcare

Overview
Date 2017 Mar 9
PMID 28269534
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Personalized healthcare systems support the provision of timely and appropriate information regarding healthcare options and treatment alternatives. Especially for patients that receive multi-drug treatments a key issue is the minimization of the risk of adverse effects due to drug-drug interactions (DDIs). DDIs may be the result of doctor prescribed drugs but also due to self-medication of conventional drugs, alternative medicines, food habits, alcohol or smoking. It is therefore crucial for personalized health systems, apart from assisting physicians for optimal prescription practices, to also provide appropriate information for individual users for drug-drug interactions or similar information regarding risks for modulation of the ensuing treatment. In this manuscript we describe a DDI service including drug-food, drug-herb and other lifestyle-related factors, developed in the context of a personalized patient empowerment platform. The solution enables guidance to patients for their medication on how to reduce the risk of unwanted drug interactions and side effects in a seamless and transparent way. We present and analyze the implemented services and provide examples on using an alerting service to identify potential DDIs in two different chronic diseases, congestive heart failure and osteoarthritis.

Citing Articles

Knowledge of Drug-Food Interactions Among Healthcare Professionals Working in Public Hospitals in Ethiopia.

Degefu N, Getachew M, Amare F J Multidiscip Healthc. 2022; 15:2635-2645.

PMID: 36411827 PMC: 9675322. DOI: 10.2147/JMDH.S389068.


Current Knowledge about Providing Drug-Drug Interaction Services for Patients-A Scoping Review.

Hammar T, Hamqvist S, Zetterholm M, Jokela P, Ferati M Pharmacy (Basel). 2021; 9(2).

PMID: 33805205 PMC: 8103271. DOI: 10.3390/pharmacy9020069.


Prevalence and Clinical Significance of Drug-Drug and Drug-Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece.

Spanakis M, Melissourgaki M, Lazopoulos G, Patelarou A, Patelarou E Pharmaceutics. 2021; 13(2).

PMID: 33572247 PMC: 7914879. DOI: 10.3390/pharmaceutics13020239.


PharmActa: Empowering Patients to Avoid Clinical Significant Drug⁻Herb Interactions.

Spanakis M, Sfakianakis S, Sakkalis V, Spanakis E Medicines (Basel). 2019; 6(1).

PMID: 30781500 PMC: 6473432. DOI: 10.3390/medicines6010026.


Association of aspartic acid repeat polymorphism in the asporin gene with osteoarthritis of knee, hip, and hand: A PRISMA-compliant meta-analysis.

Zhu X, Jiang L, Lu Y, Wang C, Zhou S, Wang H Medicine (Baltimore). 2018; 97(12):e0200.

PMID: 29561445 PMC: 5895348. DOI: 10.1097/MD.0000000000010200.